Publish or Perish v2

Communication of clinical trial outcomes is important, but the results of many clinical trials are never published. If we do not publish the results of clinical trials, the lessons learned from those trials will perish. The Oncologist offers a powerful solution through the Clinical Trial Results pub...

Descripción completa

Detalles Bibliográficos
Autor principal: Bates, Susan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656494/
https://www.ncbi.nlm.nih.gov/pubmed/31064889
http://dx.doi.org/10.1634/theoncologist.2019-0319
_version_ 1783438644682424320
author Bates, Susan E.
author_facet Bates, Susan E.
author_sort Bates, Susan E.
collection PubMed
description Communication of clinical trial outcomes is important, but the results of many clinical trials are never published. If we do not publish the results of clinical trials, the lessons learned from those trials will perish. The Oncologist offers a powerful solution through the Clinical Trial Results publishing platform, which uses an established template for authors to easily build a manuscript by simply providing the essential trial data. Through it, every patient's legacy of clinical trial enrollment can matter.
format Online
Article
Text
id pubmed-6656494
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-66564942019-07-29 Publish or Perish v2 Bates, Susan E. Oncologist Editorial Communication of clinical trial outcomes is important, but the results of many clinical trials are never published. If we do not publish the results of clinical trials, the lessons learned from those trials will perish. The Oncologist offers a powerful solution through the Clinical Trial Results publishing platform, which uses an established template for authors to easily build a manuscript by simply providing the essential trial data. Through it, every patient's legacy of clinical trial enrollment can matter. John Wiley & Sons, Inc. 2019-05-07 2019-06 /pmc/articles/PMC6656494/ /pubmed/31064889 http://dx.doi.org/10.1634/theoncologist.2019-0319 Text en © AlphaMed Press 2019
spellingShingle Editorial
Bates, Susan E.
Publish or Perish v2
title Publish or Perish v2
title_full Publish or Perish v2
title_fullStr Publish or Perish v2
title_full_unstemmed Publish or Perish v2
title_short Publish or Perish v2
title_sort publish or perish v2
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656494/
https://www.ncbi.nlm.nih.gov/pubmed/31064889
http://dx.doi.org/10.1634/theoncologist.2019-0319
work_keys_str_mv AT batessusane publishorperishv2

Ejemplares similares